Lenvatinib Mesilate

ATC — · 3 markets · 9 records

Lenvatinib Mesilate 3 markets · 9 records Forms

AU 5 records · 3 strengths

12.25 mgcapsuleARX-LENVATINIB lenvatinib 4 mg hard capsule blister pack+1LENVIMA lenvatinib 4mg hard capsule blister pack unknown
4.9 mgcapsuleARX-LENVATINIB lenvatinib 4 mg hard capsule blister pack+1LENVIMA lenvatinib 4mg hard capsule blister pack unknown

Records without a stated strength · 1 Lenvima

SG 2 records · 2 strengths

10 mgcapsuleLENVIMA HARD CAPSULES 10 MG also in TW
4 mgcapsuleLENVIMA HARD CAPSULES 10 MG also in TW

TW 2 records · 2 strengths

10 mgcapsuleLenvima+1樂衛瑪膠囊10毫克 also in SG
4 mgcapsuleLenvima+1樂衛瑪膠囊4毫克 also in SG

Side-by-side table

Strength / form / release	AU	SG	TW
10 mg capsule	not recorded	LENVIMA HARD CAPSULES 10 MG	Lenvima 樂衛瑪膠囊10毫克
4 mg capsule	not recorded	LENVIMA HARD CAPSULES 10 MG	Lenvima 樂衛瑪膠囊4毫克
12.25 mg capsule	ARX-LENVATINIB lenvatinib 4 mg hard capsule blister pack LENVIMA lenvatinib 4mg hard capsule blister pack	not recorded	not recorded
4.9 mg capsule	ARX-LENVATINIB lenvatinib 4 mg hard capsule blister pack LENVIMA lenvatinib 4mg hard capsule blister pack	not recorded	not recorded
not disclosed unknown	Lenvima	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.